The growth in the market is mainly due to the factors such as a rise in the use of prophylactic treatment for immune and bleeding diseases and increased diagnosis rate.
Sarasota, FL -- (SBWIRE) -- 09/19/2017 -- Global Plasma Fractionation Market: Overview
A process wherein the various components of blood plasma (a component of blood obtained by blood fractionation) are separated is known as blood plasma fractionation. It acts as nature's raw material which is used in dozens of life-saving treatments and medications. Blood plasma forms liquid component of whole blood and accounts for approximately 55% of the total blood volume. The main constituent of the blood plasma is water and consists of small amount of nutrients, minerals, proteins, salts and ions.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/plasma-fractionation-market
Global Plasma Fractionation Market: Growth Factors
The growth in the market is mainly due to the factors such as rise in the use of prophylactic treatment for immune and bleeding diseases and increased diagnosis rate. Rapid growth in aging population and growing use of the alpha-1-antitrypsin and immunoglobulin for various chronic diseases contribute to the growth of the global plasma fractionation market. Increasing prevalence's of the immunological and neurological diseases coupled with increasing use of intravenous immunoglobulin in various therapeutic areas propel the growth of global market. Increasing adoption of subcutaneous immunoglobulin has positively impacted the global plasma fractionation market growth. However, limited reimbursement policies, high cost of plasma products and hostile reactions linked with the use of products hamper the global market growth to some extent.
Global Plasma Fractionation Market: Segmentation
The global plasma fractionation market is classified based on the end-user as academic institutes, hospitals and clinics and clinical research laboratories. The global market is fragmented based on the application as critical care, immunology, pulmonology, neurology, rheumatology, hematology, haemato-oncology and others. On the basis of product, the global plasma fractionation market is categorized as protease inhibitors, albumin, coagulation factor concentrates, immunoglobulin and other plasma fractionation products. The immunoglobulin is dominating product segment across the globe. However, protease inhibitors contributed highest growth in the global market owing to its increasing use in respiratory diseases and other various diseases.
Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/plasma-fractionation-market
Global Plasma Fractionation Market: Regional Analysis
North America holds the largest market share in the global plasma fractionation market due to increased use of immunoglobulin in curing neurological diseases. Increasing number of hemophilic patients in North America also boost the global market growth. In addition, rising use of the prophylaxis treatments to the diagnosed patients anticipates to foster the global market growth. The Asia Pacific region is growing at a faster rate and is projected to continue this growth in the near future due to increasing use of immunoglobulin and albumin. Exponential growth in aging population and increasing number of hemophilic patients contribute to the market growth. Europe is substantially investing in R&D activities and has abundant growth opportunities fueling thus triggering the global plasma fractionation market.
Global Plasma Fractionation Market: Competitive Players
Some of the major players in the global plasma fractionation market are Kedrion S.p.A, CSL Ltd., Baxalta Incorporated, Grifols S.A., Octapharma AG and Sanquin. Other influencing players include Biotest AG, Bio Products Laboratory, Laboratoire Français du Fractionnement et des Biotechnologies and China Biologic Products, Inc.
Browse detail report @ https://www.zionmarketresearch.com/report/plasma-fractionation-market
Global Plasma Fractionation Market: Regional Segment Analysis
Middle East and Africa